Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Proactive nurse-led telephone follow-up.
- Who it may be relevant to
- Registry conditions: Breast Cancer, Colorectal Cancer, Prostate Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Sweden
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
How Are You Getting on? Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment Increases Their Sense of Security and Well-being
Overview
The goal of this randomized study is to test and evaluate nurse-led telephone follow-up intervention in patients primarily curatively treated for breast cancer, colorectal cancer, and prostate cancer. The main question aims to answer: Does this nurse-led telephone follow-up improve patients' quality of life? Participants in both groups will be asked to fill in questionnaires regularly. The intervention group will get a telephone follow-up at predetermined intervals, while the control group will get the care as usual.The investigators will compare intervention and control groups to see if predetermined regular nurse-led telephone follow-up improves quality of life.
Detailed description
The hypothesis is that nurse-led telephone follow-up will improve the quality of life in patients primarily curatively treated for breast cancer, colorectal cancer, and prostate cancer.
Participants in both groups will respond to a survey regularly during one year from inclusion. The intervention group will get a telephone follow-up at predetermined intervals (1, 3, 6, 9, 12 months) while the control group will get the care as usual. The usual care means that no proactive support is offered to patients from health care while they wait for follow-up, but patients are of course allowed to contact health care if they needed.
Participants in both groups are asked to respond on a survey concerning their quality of life, feelings of anxiety and depression, perception of illness, and experienced symptoms and discomfort regarding to cancer. Additionally, the number of visits at the health care during the waiting for follow-up will be collected from both group.
Interventions
- Behavioral Proactive nurse-led telephone follow-up
An intervention nurse call the patients regularly with predetermined intervals and give support
Primary outcome measures
- Patients' reported Quality of life [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
Secondary outcome measures (6)
- Patients' reported anxiety and depression [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
- Patients' reported quality [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
- Patients' perceptions of illness [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
- Patients' experiences of breast cancer related to body image, sexual functioning, systemic therapy side effects and symptoms [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
- Patients' experiences of colorectal cancer related to symptoms and side effects of treatment and diagnosis. [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
- Patients' experiences of prostata cancer related to symptoms and side effects of treatment and diagnosis. [Time frame: Baseline, 3 months, 6 months and 12 months from inclusion]
Eligibility criteria
Inclusion criteria
- Being primarily curatively treated for breast, colorectal-, or prostate cancer
Exclusion criteria
- no adjuvant treatment
- no cognitive impairment
- no known alcohol or other misuse
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Supportive care
Study locations
Sweden · 1 center
- Norrlands universitetssjukhus — Umeå
Identifiers
NCT: NCT06223022 · Department of Nursing